Gemcitabine and etoposide in small cell lung cancer: Phase I and II trials

Seminars in Oncology

Volumn 24, Issue 2 SUPPL. 7, 1997, Pages

  Rabmann, I ^a   Thodtmann, R ^a   Depenbrock, H ^a   Blatter, J ^a   Gatzermeier, U ^a   Rastetter, J ^a   Hanauske, A R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; GEMCITABINE;

ADULT; ANEMIA; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; LUNG SMALL CELL CANCER; MALE; NEPHROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 0030958261     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)